Jim Cramer's Stop Trading! Buy Celgene
Buy Celgene (CELG), Jim Cramer said Monday on CNBC's "Stop Trading!" segment.
Cramer said he believes that research unveiled this weekend on the company's Revlimid cancer drug shows that the stock has great upside. But Monday's flat stock performance shows the development is a "tree falling in the woods." Cramer believes the stock, up 50% over the last year at $61 and change, is "ready to roll again." Cramer also likes Wal-Mart (WMT), saying the stock's second straight 3% daily gain isn't a reason to wait for a pullback. Cramer said he agrees with an HSBC analyst's call that the stock could go to $61 in the next year from $50 and change Monday. Cramer believes a Bear Stearns analyst's upgrade of Sirius (SIRI) is a "big call" and that the analyst's track record should make investors take notice. Cramer said the call isn't working Monday, with the stock down 3 cents at $2.85, but he believes it could turn around and hit Bear's $4 price target.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,801.23 | 1,342.64 | 2,903.88 | 19.69 |
Oil *
117.67
|
|
DOWN
89.23 |
DOWN
9.31 |
DOWN
23.35 |
DOWN
0.78 |
10 Yr
1.97%
SPDR Gold
167.14
|
|
-0.69%
|
-0.69%
|
-0.80%
|
-3.81%
|
Data delayed 20 minutes |

Connect with TheStreet